Kawasaki syndrome in SARS-CoV-2 patients

Authors

DOI:

https://doi.org/10.35381/s.v.v5i1.1605

Keywords:

Mucocutaneous lymph node syndrome, SARS-CoV, Pacientes. (Source, DeCS)

Abstract

Kawasaki syndrome in SARS-CoV-2 patients

Downloads

Download data is not yet available.

References

Yeung RS, Ferguson PJ. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?. J Clin Invest. 2020;130(11):5681-5684. doi:10.1172/JCI141718

Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases. Int J Infect Dis. 2020;97:371-373. doi:10.1016/j.ijid.2020.06.014

Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130(11):5942-5950. doi:10.1172/JCI141113

Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324(3):259-269. doi:10.1001/jama.2020.10369

Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel). 2020;7(7):69. Published 2020 Jul 1. doi:10.3390/children7070069

Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-322. doi:10.1007/s00431-020-03766-6

Downloads

Published

2021-12-01

How to Cite

Wong-Vásquez, L., Carrión-Molina, A. P., & Sagnai-Saltos, J. E. (2021). Kawasaki syndrome in SARS-CoV-2 patients. Revista Arbitrada Interdisciplinaria De Ciencias De La Salud. Salud Y Vida, 5(1), 157–160. https://doi.org/10.35381/s.v.v5i1.1605

Issue

Vol. 5 No. 1 (5): Especial. 2021

Section

Carta al Editor

License

CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos. 

 

OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai. 

 

Most read articles by the same author(s)